{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T05:18:05Z","timestamp":1791609485437,"version":"4.3.4"},"reference-count":92,"publisher":"American Medical Association (AMA)","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2018,12,25]]},"DOI":"10.1001\/jama.2018.19319","type":"journal-article","created":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T11:06:26Z","timestamp":1545390386000},"page":"2564","source":"Crossref","is-referenced-by-count":310,"title":["Association of Pharmacological Treatments With Long-term Pain Control in Patients With Knee Osteoarthritis"],"prefix":"10.1001","volume":"320","author":[{"given":"Dario","family":"Gregori","sequence":"first","affiliation":[{"name":"Unit of Biostatistics, Epidemiology, and Public Health, Department of Cardiac, Thoracic, and Vascular Sciences, University of Padova, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giampaolo","family":"Giacovelli","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Rottapharm Biotech, Monza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Minto","sequence":"additional","affiliation":[{"name":"Unit of Biostatistics, Epidemiology, and Public Health, Department of Cardiac, Thoracic, and Vascular Sciences, University of Padova, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Barbetta","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Rottapharm Biotech, Monza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Gualtieri","sequence":"additional","affiliation":[{"name":"Scientific Information and Library Services, Rottapharm Biotech, Monza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danila","family":"Azzolina","sequence":"additional","affiliation":[{"name":"Unit of Biostatistics, Epidemiology, and Public Health, Department of Cardiac, Thoracic, and Vascular Sciences, University of Padova, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Vaghi","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Rottapharm Biotech, Monza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucio C.","family":"Rovati","sequence":"additional","affiliation":[{"name":"Department of Clinical Research, Rottapharm Biotech, Monza, Italy"},{"name":"School of Medicine and Surgery, University of Milano\u2009\u2013\u2009Bicocca, Monza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"10053","key":"joi180145r1","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/S0140-6736(16)31678-6","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.","volume":"388","author":"GBD 2015 Disease and Injury Incidence and Prevalence Collaborators","year":"2016","journal-title":"Lancet"},{"issue":"14","key":"joi180145r2","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1001\/jama.2018.0158","article-title":"The state of US health, 1990-2016: burden of diseases, injuries, and risk factors among US states.","volume":"319","author":"Mokdad","year":"2018","journal-title":"JAMA"},{"issue":"9991","key":"joi180145r3","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/S0140-6736(14)60802-3","article-title":"Osteoarthritis.","volume":"386","author":"Glyn-Jones","year":"2015","journal-title":"Lancet"},{"issue":"5","key":"joi180145r4","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.joca.2010.09.013","article-title":"OARSI-FDA initiative: defining the disease state of osteoarthritis.","volume":"19","author":"Lane","year":"2011","journal-title":"Osteoarthritis Cartilage"},{"issue":"4","key":"joi180145r5","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/acr.21596","article-title":"American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee.","volume":"64","author":"Hochberg","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"joi180145r6","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.joca.2014.01.003","article-title":"OARSI guidelines for the non-surgical management of knee osteoarthritis.","volume":"22","author":"McAlindon","year":"2014","journal-title":"Osteoarthritis Cartilage"},{"issue":"2","key":"joi180145r7","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/jrsm.1037","article-title":"Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool.","volume":"3","author":"Salanti","year":"2012","journal-title":"Res Synth Methods"},{"issue":"11","key":"joi180145r8","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations.","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"key":"joi180145r11","doi-asserted-by":"publisher","first-page":"136245","DOI":"10.1155\/2012\/136245","article-title":"A hierarchy of patient-reported outcomes for meta-analysis of knee osteoarthritis trials: empirical evidence from a survey of high impact journals.","volume":"2012","author":"Juhl","year":"2012","journal-title":"Arthritis"},{"issue":"12","key":"joi180145r12","first-page":"1833","article-title":"Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee.","volume":"15","author":"Bellamy","year":"1988","journal-title":"J Rheumatol"},{"key":"joi180145r13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-2288-12-9","article-title":"Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves.","volume":"12","author":"Guyot","year":"2012","journal-title":"BMC Med Res Methodol"},{"key":"joi180145r14","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials.","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"joi180145r15","doi-asserted-by":"publisher","first-page":"c3515","DOI":"10.1136\/bmj.c3515","article-title":"Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study.","volume":"341","author":"N\u00fcesch","year":"2010","journal-title":"BMJ"},{"issue":"24","key":"joi180145r16","doi-asserted-by":"publisher","first-page":"3823","DOI":"10.1002\/(ISSN)1097-0258","article-title":"Meta-analysis of heterogeneously reported trials assessing change from baseline.","volume":"24","author":"Abrams","year":"2005","journal-title":"Stat Med"},{"issue":"5","key":"joi180145r17","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1177\/0272989X12458724","article-title":"Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials.","volume":"33","author":"Dias","year":"2013","journal-title":"Med Decis Making"},{"issue":"12","key":"joi180145r20","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1016\/j.joca.2015.07.001","article-title":"Recommendations for an update of the 2010 European regulatory guideline on clinical investigation of medicinal products used in the treatment of osteoarthritis and reflections about related clinically relevant outcomes: expert consensus statement.","volume":"23","author":"Reginster","year":"2015","journal-title":"Osteoarthritis Cartilage"},{"issue":"7-8","key":"joi180145r22","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/sim.3767","article-title":"Checking consistency in mixed treatment comparison meta-analysis.","volume":"29","author":"Dias","year":"2010","journal-title":"Stat Med"},{"issue":"4","key":"joi180145r23","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/jrsm.1054","article-title":"Automating network meta-analysis.","volume":"3","author":"van Valkenhoef","year":"2012","journal-title":"Res Synth Methods"},{"issue":"5","key":"joi180145r24","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1177\/0272989X13485157","article-title":"Evidence synthesis for decision making 3: heterogeneity\u2014subgroups, meta-regression, bias, and bias-adjustment.","volume":"33","author":"Dias","year":"2013","journal-title":"Med Decis Making"},{"issue":"4","key":"joi180145r26","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1080\/10618600.1998.10474787","article-title":"General methods for monitoring convergence of iterative simulations.","volume":"7","author":"Brooks","year":"1998","journal-title":"J Comput Graph Stat"},{"issue":"2","key":"joi180145r27","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial.","volume":"64","author":"Salanti","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"joi180145r31","first-page":"65","article-title":"Guidelines for testing slow acting drugs in osteoarthritis.","volume":"41","author":"Lequesne","year":"1994","journal-title":"J Rheumatol Suppl"},{"issue":"4","key":"joi180145r33","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1586\/ecp.09.17","article-title":"Glucosamine therapy for knee osteoarthritis: pharmacokinetic considerations.","volume":"2","author":"Altman","year":"2009","journal-title":"Expert Rev Clin Pharmacol"},{"key":"joi180145r34","first-page":"CD002946","article-title":"Glucosamine therapy for treating osteoarthritis.","volume":"2","author":"Towheed","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"joi180145r35","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1002\/acr.v66.12","article-title":"Risk of bias and brand explain the observed inconsistency in trials on glucosamine for symptomatic relief of osteoarthritis: a meta-analysis of placebo-controlled trials.","volume":"66","author":"Eriksen","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"11","key":"joi180145r36","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1016\/j.joca.2016.05.020","article-title":"The effect of vitamin D supplementation on knee osteoarthritis, the VIDEO study: a randomised controlled trial.","volume":"24","author":"Arden","year":"2016","journal-title":"Osteoarthritis Cartilage"},{"issue":"11","key":"joi180145r37","doi-asserted-by":"publisher","first-page":"3494","DOI":"10.1002\/(ISSN)1529-0131","article-title":"Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study.","volume":"54","author":"Bingham","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"5","key":"joi180145r38","first-page":"857","article-title":"HYADD 4 versus methylprednisolone acetate in symptomatic knee osteoarthritis: a single-centre single blind prospective randomised controlled clinical study with 1-year follow-up.","volume":"34","author":"Bisicchia","year":"2016","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"joi180145r39","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1002\/(ISSN)1529-0131","article-title":"Effects of doxycycline on progression of osteoarthritis: results of a randomized, placebo-controlled, double-blind trial.","volume":"52","author":"Brandt","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"5","key":"joi180145r40","first-page":"937","article-title":"Quantitative microfocal radiography detects changes in OA knee joint space width in patients in placebo controlled trial of NSAID therapy.","volume":"22","author":"Buckland-Wright","year":"1995","journal-title":"J Rheumatol"},{"issue":"5","key":"joi180145r41","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1002\/1529-0131(200005)43:5<978::AID-ANR4>3.0.CO;2-0","article-title":"Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip.","volume":"43","author":"Cannon","year":"2000","journal-title":"Arthritis Rheum"},{"key":"joi180145r42","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/1471-2474-6-58","article-title":"Etoricoxib in the treatment of osteoarthritis over 52-weeks: a double-blind, active-comparator controlled trial [NCT00242489].","volume":"6","author":"Curtis","year":"2005","journal-title":"BMC Musculoskelet Disord"},{"issue":"2","key":"joi180145r43","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1080\/03009740802419065","article-title":"A randomized, multicentre, double-blind, parallel-group study to assess the adverse event-related discontinuation rate with celecoxib and diclofenac in elderly patients with osteoarthritis.","volume":"38","author":"Dahlberg","year":"2009","journal-title":"Scand J Rheumatol"},{"issue":"2","key":"joi180145r44","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S1063-4584(05)80024-X","article-title":"High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a 1 year placebo-controlled trial.","volume":"1","author":"Dougados","year":"1993","journal-title":"Osteoarthritis Cartilage"},{"issue":"11","key":"joi180145r45","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.1007\/s00167-014-3398-2","article-title":"Will a single periarticular lidocaine-corticosteroid injection improve the clinical efficacy of intraarticular hyaluronic acid treatment of symptomatic knee osteoarthritis?","volume":"24","author":"Ert\u00fcrk","year":"2016","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"issue":"5","key":"joi180145r46","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1136\/annrheumdis-2013-203954","article-title":"Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebo-controlled clinical trial evaluating single and combination regimens.","volume":"74","author":"Fransen","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"joi180145r47","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.2147\/TCRM","article-title":"Effectiveness of etofenamate for treatment of knee osteoarthritis: a randomized controlled trial.","volume":"12","author":"G\u00fcner","year":"2016","journal-title":"Ther Clin Risk Manag"},{"issue":"2","key":"joi180145r48","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1136\/annrheumdis-2012-202239","article-title":"A 2-year randomised, double-blind, placebo-controlled, multicentre study of oral selective iNOS inhibitor, cindunistat (SD-6010), in patients with symptomatic osteoarthritis of the knee.","volume":"72","author":"Hellio le Graverand","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"joi180145r49","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1136\/ard.2009.118042","article-title":"Intra-articular hyaluronan is without clinical effect in knee osteoarthritis: a multicentre, randomised, placebo-controlled, double-blind study of 337 patients followed for 1 year.","volume":"69","author":"J\u00f8rgensen","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"joi180145r50","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1742-1241.2003.tb10535.x","article-title":"A one-year, randomised, placebo (saline) controlled clinical trial of 500-730 kDa sodium hyaluronate (Hyalgan) on the radiological change in osteoarthritis of the knee.","volume":"57","author":"Jubb","year":"2003","journal-title":"Int J Clin Pract"},{"issue":"2","key":"joi180145r51","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1002\/art.v60:2","article-title":"Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: the study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-controlled trial.","volume":"60","author":"Kahan","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"11","key":"joi180145r52","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1093\/rheumatology\/41.11.1240","article-title":"Comparison of two hyaluronan drugs and placebo in patients with knee osteoarthritis: a controlled, randomized, double-blind, parallel-design multicentre study.","volume":"41","author":"Karlsson","year":"2002","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"joi180145r53","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.joca.2014.12.019","article-title":"Treatment of symptomatic knee osteoarthritis with oral salmon calcitonin: results from two phase 3 trials.","volume":"23","author":"Karsdal","year":"2015","journal-title":"Osteoarthritis Cartilage"},{"issue":"3","key":"joi180145r54","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00774-007-0813-5","article-title":"Additive effects of glucosamine or risedronate for the treatment of osteoarthritis of the knee combined with home exercise: a prospective randomized 18-month trial.","volume":"26","author":"Kawasaki","year":"2008","journal-title":"J Bone Miner Metab"},{"issue":"8","key":"joi180145r55","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1742-1241.2001.tb11112.x","article-title":"Double-blind study comparing the long-term efficacy of the COX-2 inhibitor nimesulide and naproxen in patients with osteoarthritis.","volume":"55","author":"Kriegel","year":"2001","journal-title":"Int J Clin Pract"},{"issue":"5","key":"joi180145r56","doi-asserted-by":"publisher","first-page":"R109","DOI":"10.1186\/ar2315","article-title":"Development of musculoskeletal toxicity without clear benefit after administration of PG-116800, a matrix metalloproteinase inhibitor, to patients with knee osteoarthritis: a randomized, 12-month, double-blind, placebo-controlled study.","volume":"9","author":"Krzeski","year":"2007","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"joi180145r57","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1136\/annrheumdis-2011-200970","article-title":"Zoledronic acid reduces knee pain and bone marrow lesions over 1 year: a randomised controlled trial.","volume":"71","author":"Laslett","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"joi180145r58","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.joca.2013.10.009","article-title":"NASHA hyaluronic acid vs methylprednisolone for knee osteoarthritis: a prospective, multi-centre, randomized, non-inferiority trial.","volume":"22","author":"Leighton","year":"2014","journal-title":"Osteoarthritis Cartilage"},{"issue":"3","key":"joi180145r59","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S1063-4584(97)80010-6","article-title":"Arthroscopic evaluation of potential structure modifying activity of hyaluronan (Hyalgan) in osteoarthritis of the knee.","volume":"5","author":"Listrat","year":"1997","journal-title":"Osteoarthritis Cartilage"},{"issue":"7","key":"joi180145r60","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1002\/art.v66.7","article-title":"Intraarticular sprifermin (recombinant human fibroblast growth factor 18) in knee osteoarthritis: a randomized, double-blind, placebo-controlled trial.","volume":"66","author":"Lohmander","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"29","key":"joi180145r61","first-page":"1386","article-title":"Radiological progression of internal femoro-tibial osteoarthritis in gonarthrosis: chondro-protective effect of chondroitin sulfates ACS4-ACS6","volume":"31","author":"Mathieu","year":"2002","journal-title":"Presse Med"},{"issue":"2","key":"joi180145r62","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1001\/jama.2012.164487","article-title":"Effect of vitamin D supplementation on progression of knee pain and cartilage volume loss in patients with symptomatic osteoarthritis: a randomized controlled trial.","volume":"309","author":"McAlindon","year":"2013","journal-title":"JAMA"},{"issue":"19","key":"joi180145r63","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1001\/jama.2017.5283","article-title":"Effect of intra-articular triamcinolone vs saline on knee cartilage volume and pain in patients with knee osteoarthritis: a randomized clinical trial.","volume":"317","author":"McAlindon","year":"2017","journal-title":"JAMA"},{"issue":"3","key":"joi180145r64","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1002\/(ISSN)1529-0131","article-title":"Chondroitins 4 and 6 sulfate in osteoarthritis of the knee: a randomized, controlled trial.","volume":"52","author":"Michel","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"4","key":"joi180145r65","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s00296-005-0584-z","article-title":"The safety and efficacy of intraarticular hyaluronan with\/without corticosteroid in knee osteoarthritis: 1-year, single-blind, randomized study.","volume":"26","author":"Ozturk","year":"2006","journal-title":"Rheumatol Int"},{"issue":"18","key":"joi180145r66","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1001\/archinte.162.18.2113","article-title":"Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study.","volume":"162","author":"Pavelk\u00e1","year":"2002","journal-title":"Arch Intern Med"},{"issue":"1","key":"joi180145r67","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/s13075-016-1149-0","article-title":"Chondroitin sulfate efficacy versus celecoxib on knee osteoarthritis structural changes using magnetic resonance imaging: a 2-year multicentre exploratory study.","volume":"18","author":"Pelletier","year":"2016","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"joi180145r68","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1136\/ard.2003.019703","article-title":"Evaluation of the symptomatic and structural efficacy of a new hyaluronic acid compound, NRD101, in comparison with diacerein and placebo in a 1 year randomised controlled study in symptomatic knee osteoarthritis.","volume":"63","author":"Pham","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"joi180145r69","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/(ISSN)1529-0131","article-title":"Safety and efficacy of long-term intraarticular steroid injections in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled trial.","volume":"48","author":"Raynauld","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"6","key":"joi180145r70","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1136\/ard.2008.088732","article-title":"Protective effects of licofelone, a 5-lipoxygenase and cyclo-oxygenase inhibitor, versus naproxen on cartilage loss in knee osteoarthritis: a first multicentre clinical trial using quantitative MRI.","volume":"68","author":"Raynauld","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"9252","key":"joi180145r71","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0140-6736(00)03610-2","article-title":"Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial.","volume":"357","author":"Reginster","year":"2001","journal-title":"Lancet"},{"issue":"7","key":"joi180145r72","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1136\/ard.2006.059162","article-title":"Evaluation of the efficacy and safety of etoricoxib compared with naproxen in two, 138-week randomised studies of patients with osteoarthritis.","volume":"66","author":"Reginster","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"joi180145r73","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1136\/annrheumdis-2012-202231","article-title":"Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial.","volume":"72","author":"Reginster","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"joi180145r74","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1001\/archfami.9.10.1124","article-title":"Rofecoxib, a new cyclooxygenase 2 inhibitor, shows sustained efficacy, comparable with other nonsteroidal anti-inflammatory drugs: a 6-week and a 1-year trial in patients with osteoarthritis.","volume":"9","author":"Saag","year":"2000","journal-title":"Arch Fam Med"},{"issue":"10","key":"joi180145r75","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1002\/art.v58:10","article-title":"The effect of glucosamine and\/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the Glucosamine\/Chondroitin Arthritis Intervention Trial.","volume":"58","author":"Sawitzke","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"8","key":"joi180145r76","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1136\/ard.2009.120469","article-title":"Clinical efficacy and safety of glucosamine, chondroitin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year results from GAIT.","volume":"69","author":"Sawitzke","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"joi180145r77","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1093\/rheumatology\/39.10.1095","article-title":"The long-term effects of non-steroidal anti-inflammatory drugs in osteoarthritis of the knee: a randomized placebo-controlled trial.","volume":"39","author":"Scott","year":"2000","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"joi180145r78","doi-asserted-by":"publisher","first-page":"R625","DOI":"10.1186\/ar1716","article-title":"Effect of risedronate on joint structure and symptoms of knee osteoarthritis: results of the BRISK randomized, controlled trial [ISRCTN01928173].","volume":"7","author":"Spector","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"joi180145r79","first-page":"9","article-title":"Clinical efficacy of intra-articular injections in knee osteoarthritis: a prospective randomized study comparing hyaluronic acid and betamethasone.","volume":"7","author":"Trueba Davalillo","year":"2015","journal-title":"Open Access Rheumatol"},{"issue":"4","key":"joi180145r80","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.joca.2004.01.004","article-title":"Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: a one-year, randomized, double-blind, multicenter study versus placebo","volume":"12","author":"Uebelhart","year":"2004","journal-title":"Osteoarthritis Cartilage"},{"issue":"9","key":"joi180145r81","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1002\/(ISSN)1529-0131","article-title":"Comparison of naproxen and acetaminophen in a two-year study of treatment of osteoarthritis of the knee.","volume":"36","author":"Williams","year":"1993","journal-title":"Arthritis Rheum"},{"issue":"12","key":"joi180145r82","first-page":"2585","article-title":"Supplementary vitamin E does not affect the loss of cartilage volume in knee osteoarthritis: a 2 year double blind randomized placebo controlled study.","volume":"29","author":"Wluka","year":"2002","journal-title":"J Rheumatol"},{"key":"joi180145r83","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1136\/ard.16.4.494","article-title":"Radiological assessment of osteo-arthrosis.","volume":"16","author":"Kellgren","year":"1957","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"joi180145r84","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/ppr.2012.12.issue-7","article-title":"Use and costs of prescription medications and alternative treatments in patients with osteoarthritis and chronic low back pain in community-based settings.","volume":"12","author":"Gore","year":"2012","journal-title":"Pain Pract"},{"issue":"1","key":"joi180145r85","doi-asserted-by":"publisher","first-page":"46","DOI":"10.7326\/M14-1231","article-title":"Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis.","volume":"162","author":"Bannuru","year":"2015","journal-title":"Ann Intern Med"},{"issue":"10090","key":"joi180145r86","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/S0140-6736(17)31744-0","article-title":"Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis.","volume":"390","author":"da Costa","year":"2017","journal-title":"Lancet"},{"issue":"3","key":"joi180145r87","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.semarthrit.2014.05.014","article-title":"An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: a report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).","volume":"44","author":"Bruy\u00e8re","year":"2014","journal-title":"Semin Arthritis Rheum"},{"issue":"26","key":"joi180145r88","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1056\/NEJMoa1611593","article-title":"Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis.","volume":"375","author":"Nissen","year":"2016","journal-title":"N Engl J Med"},{"issue":"12","key":"joi180145r89","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1002\/art.v61:12","article-title":"Therapeutic trajectory of hyaluronic acid versus corticosteroids in the treatment of knee osteoarthritis: a systematic review and meta-analysis.","volume":"61","author":"Bannuru","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"2","key":"joi180145r90","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.bone.2012.01.008","article-title":"Role of bone architecture and anatomy in osteoarthritis.","volume":"51","author":"Baker-LePain","year":"2012","journal-title":"Bone"},{"issue":"10","key":"joi180145r91","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/S1063-4584(03)00166-3","article-title":"Relief in mild-to-moderate pain is not a confounder in joint space narrowing assessment of full extension knee radiographs in recent osteoarthritis structure-modifying drug trials.","volume":"11","author":"Pavelka","year":"2003","journal-title":"Osteoarthritis Cartilage"},{"issue":"7","key":"joi180145r92","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1136\/annrheumdis-2012-202745","article-title":"EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis.","volume":"72","author":"Fernandes","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"joi180145r18","volume-title":"Meta-analysis in Social Research","author":"Glass","year":"1981"},{"key":"joi180145r19","volume-title":"Statistical Power Analysis for the Behavioural Sciences","author":"Cohen","year":"1988","edition":"2nd ed"},{"key":"joi180145r21","volume-title":"Bayesian Approaches to Clinical Trials and Health-Care Evaluation","author":"Spiegelhalter","year":"2004"},{"key":"joi180145r25","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-21416-0","volume-title":"Meta-analysis With R","author":"Schwarzer","year":"2015"},{"key":"joi180145r30","doi-asserted-by":"crossref","DOI":"10.1201\/b13613","volume-title":"The BUGS Book: A Practical Introduction to Bayesian Analysis","author":"Lunn","year":"2012"},{"key":"joi180145r9","unstructured":"NewberrySJ, FitzGeraldJ, SooHooNF, . Treatment of osteoarthritis of the knee: an update review. https:\/\/effectivehealthcare.ahrq.gov\/topics\/osteoarthritis-knee-update\/research-2017. Accessed November 20, 2018."},{"key":"joi180145r10","unstructured":"Core Outcome Measures in Effectiveness Trials Initiative. Core outcome measures in effectiveness trials. http:\/\/www.comet-initiative.org. Accessed March 21, 2018."},{"key":"joi180145r28","unstructured":"RStudio Team. RStudio integrated development for R. https:\/\/www.rstudio.com\/. Accessed November 20, 2018."},{"key":"joi180145r29","unstructured":"van ValkenhoefG, KuiperJ. gemtc: network meta-analysis using Bayesian methods: R package version 0.8. http:\/\/cran.r-project.org\/web\/packages\/gemtc\/index.html. Accessed November 20, 2018."},{"key":"joi180145r32","unstructured":"De WanM, VolpiG. A method of preparing mixed glucosamine salts: US patent 5,847,107. https:\/\/patents.google.com\/patent\/US5847107A\/en. Accessed November 20, 2018."}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2719308","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T11:23:17Z","timestamp":1720869797000},"score":1,"resource":{"primary":{"URL":"http:\/\/jama.jamanetwork.com\/article.aspx?doi=10.1001\/jama.2018.19319"}},"subtitle":["A Systematic Review and Meta-analysis"],"short-title":[],"issued":{"date-parts":[[2018,12,25]]},"references-count":92,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2018,12,25]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2018.19319","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12,25]]}}}